Patent Assignment
Reel/Frame 027463/0613
Security Agreement
Recorded: 2011-12-29
Pages: 9
Assignor
PROTIVA BIOTHERAPEUTICS, INC.
Executed: 2011-12-21
Assignee
SILICON VALLEY BANK
3003 TASMAN DRIVE, SANTA CLARA, CALIFORNIA, 95054
Covered Properties
(38)
Sensitizing Cells to Compounds Using Lipid-Mediated Gene and Compound Delivery
Patent:
6,410,328 →
Application:
09/243,104 →
Combination Therapy Using Nucleic Acids and Conventional Drugs
Patent:
6,841,537 →
Application:
09/295,663 →
Combination Therapy Using Nucleic Acids and Radio Therapy
Patent:
6,841,538 →
Application:
09/295,925 →
Lipid-Based Formulations
Application:
10/136,707 →
Publication:
US 2003/0077829
Autogene Nucleic Acids Encoding a Secretable Rna Polymerase
Liposomal Apparatus and Manufacturing Methods
Lipid encapsulated interfering RNA
Application:
10/893,121 →
Publication:
US 2005/0064595
Polyethyleneglycol-Modified Lipid Compounds and Uses Thereof
Systemic delivery of serum stable plasmid lipid particles for cancer therapy
Application:
10/954,858 →
Publication:
US 2005/0118253
Lipid Encapsulated Interfering Rna
Cationic Lipids and Methods of Use
Compositions Comprising Immunostimulatory Sirna Molecules and Dlindma or Dlendma
Compositions for the delivery of therapeutic agents and uses thereof
Application:
11/185,447 →
Publication:
US 2006/0051405
siRNA silencing of apolipoprotein B
Application:
11/283,550 →
Publication:
US 2006/0134189
Thioureas as factor Xa inhibitors
Application:
11/298,296 →
Publication:
US 2006/0160790
Lipid Encapsulated Interfering Rna
Systems and Methods for Manufacturing Liposomes
Glucocorticoid modulation of nucleic acid-mediated immune stimulation
Application:
11/511,855 →
Publication:
US 2007/0054873
Sirna Silencing of Filovirus Gene Expression
Modified Sirna Molecules and Uses Thereof
siRNA silencing of influenza virus gene expression
Application:
11/601,437 →
Publication:
US 2007/0218122
Modified Sirna Molecules and Uses Thereof
siRNA silencing of genes expressed in cancer
Nucleic Acid Modulation of Toll-Like Receptor-Mediated Immune Stimulation
Application:
11/839,065 →
Publication:
US 2008/0171716
Silencing of Polo-Like Kinase Expression Using Interfering Rna
Novel Lipid Formulations for Nucleic Acid Delivery
siRNA SILENCING OF APOLIPOPROTEIN B
Application:
12/784,402 →
Publication:
US 2011/0189300
Lipid Encapsulated Dicer-Substrate Interfering Rna
Application:
12/794,701 →
Publication:
US 2011/0071208
Cationic Lipids and Methods of Use
Application:
12/796,573 →
Publication:
US 2011/0262527
Lipid Formulations for Nucleic Acid Delivery
Compositions and Methods for Silencing Apolipoprotein B
Compositions and Methods for Silencing Ebola Virus Gene Expression
Polyethyleneglycol-Modified Lipid Compounds and Uses Thereof
Lipid Encapsulating Interfering Rna
siRNA SILENCING OF FILOVIRUS GENE EXPRESSION
Application:
12/878,946 →
Publication:
US 2011/0177131
Silencing of CSN5 Gene Expression Using Interfering Rna
Liposomal Apparatus and Manufacturing Method
MODIFIED sIRNA MOLECULES AND USES THEREOF
Application:
13/026,898 →
Publication:
US 2011/0224418
Related Assignments
(19)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Mar 29, 2004
From: MACLACHLAN, IAN; JEFFS, LLOYD; PALMER, LORNE R.
To: PROTIVA BIOTHERAPEUTICS, INC.
Reel/Frame 015220/0516 →
Assignment of Assignor's Interest
Apr 12, 2004
From: FINN, JOHN; MACLACHLAN, IAN
To: THE UNIVERSITY OF BRITISH COLUMBIA
Reel/Frame 014511/0400 →
Assignment of Assignor's Interest
Jul 6, 2004
From: NOELLE GIESBRECHT, LEGAL REPRESENTATIVE FOR CORY GIESBRECHT (DECEASED)
To: PROTIVA BIOTHERAPEUTICS, INC.
Reel/Frame 014821/0744 →
Assignment of Assignor's Interest
Nov 29, 2004
From: MACLACHLAN, IAN; AMBEGIA, ELLEN GRACE; HEYES, JAMES
To: PROTIVA BIOTHERAPEUTICS, INC.
Reel/Frame 015413/0405 →
Assignment of Assignor's Interest
Jan 13, 2005
From: MACLACHLAN, IAN
To: PROTIVA BIOTHERAPEUTICS, INC.
Reel/Frame 015594/0086 →
Assignment of Assignor's Interest
Apr 12, 2005
From: HEYES, JAMES; MACLACHLAN, IAN; AMBEGIA, ELLEN GRACE
To: PROTIVA BIOTHERAPEUTICS, INC.
Reel/Frame 016057/0993 →
Assignment of Assignor's Interest
Aug 30, 2005
From: MACLACHLAN, IAN; PALMER, LORNE R.; HEYES, JAMES
To: PROTIVIA BIOTHERAPEUTICS, INC.
Reel/Frame 016471/0770 →
Assignment of Assignor's Interest
Oct 17, 2005
From: MACLACHLAN, IAN; JUDGE, ADAM
To: PROTIVA BIOTHERAPEUTICS, INC.
Reel/Frame 016648/0159 →
Assignment of Assignor's Interest
Nov 15, 2005
From: MACLACHLAN, IAN; JEFFS, LLOYD
To: PROTIVA BIOTHERAPEUTICS, INC.
Reel/Frame 016782/0406 →
Assignment of Assignor's Interest
Dec 21, 2005
From: HEYES, JAMES; MACLACHLAN, IAN; PALMER, LORNE R.
To: PROTIVA BIOTHERAPEUTICS, INC.
Reel/Frame 017137/0926 →
Assignment of Assignor's Interest
Feb 16, 2006
From: MACLACHLAN, IAN; JEFFS, LLOYD B.; JUDGE, ADAM; LEE, AMY C.H.
To: PROTIVA BIOTHERAPEUTICS, INC.
Reel/Frame 017269/0696 →
Assignment of Assignor's Interest
Mar 27, 2006
From: SONG, YONGHONG; ZHU, BING-YAN; BHAKTA, CHHAYA; SCARBOROUGH, ROBERT M.
To: PROTIVA BIOTHERAPEUTICS, INC.
Reel/Frame 017369/0371 →
Assignment of Assignor's Interest
Dec 9, 2009
From: HEYES, JAMES
To: PROTIVA BIOTHERAPEUTICS, INC.
Reel/Frame 023628/0668 →
Assignment of Assignor's Interest
Feb 9, 2010
From: HEYES, JAMES; PALMER, LORNE
To: PROTIVA BIOTHERAPEUTICS, INC.
Reel/Frame 023916/0712 →
Assignment of Assignor's Interest
Jun 10, 2011
From: MACLACHLAN, IAN; AMBEGIA, ELLEN GRACE; HEYES, JAMES
To: PROTIVA BIOTHERAPEUTICS, INC.
Reel/Frame 026429/0205 →
Merger
Feb 20, 2018
From: PROTIVA BIOTHERAPEUTICS INC.
To: ARBUTUS BIOPHARMA CORPORATION
Reel/Frame 045384/0278 →
Change of Name
Jan 12, 2021
From: PORTOLA PHARMACEUTICALS, INC.
To: PORTOLA PHARMACEUTICALS, LLC
Reel/Frame 054976/0294 →
Assignment of Assignor's Interest
Jan 12, 2021
From: PORTOLA PHARMACEUTICALS, LLC
To: ALEXION PHARMACEUTICALS, INC.
Reel/Frame 054975/0203 →
Release of Security Interest
Feb 16, 2023
From: SILICON VALLEY BANK
To: PROTIVA BIOTHERAPEUTICS, INC.
Reel/Frame 062721/0199 →